Structure

Physi-Chem Properties

Molecular Weight:  560.33
Volume:  584.942
LogP:  2.872
LogD:  2.842
LogS:  -4.172
# Rotatable Bonds:  6
TPSA:  141.36
# H-Bond Aceptor:  8
# H-Bond Donor:  4
# Rings:  4
# Heavy Atoms:  8

MedChem Properties

QED Drug-Likeness Score:  0.228
Synthetic Accessibility Score:  5.439
Fsp3:  0.781
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  0
Golden Triangle Rule:  Rejected
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.047
MDCK Permeability:  1.3370532542467117e-05
Pgp-inhibitor:  0.988
Pgp-substrate:  0.105
Human Intestinal Absorption (HIA):  0.077
20% Bioavailability (F20%):  0.084
30% Bioavailability (F30%):  0.188

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.821
Plasma Protein Binding (PPB):  65.28640747070312%
Volume Distribution (VD):  0.478
Pgp-substrate:  19.67964744567871%

ADMET: Metabolism

CYP1A2-inhibitor:  0.004
CYP1A2-substrate:  0.094
CYP2C19-inhibitor:  0.02
CYP2C19-substrate:  0.79
CYP2C9-inhibitor:  0.03
CYP2C9-substrate:  0.595
CYP2D6-inhibitor:  0.008
CYP2D6-substrate:  0.13
CYP3A4-inhibitor:  0.603
CYP3A4-substrate:  0.583

ADMET: Excretion

Clearance (CL):  3.091
Half-life (T1/2):  0.453

ADMET: Toxicity

hERG Blockers:  0.015
Human Hepatotoxicity (H-HT):  0.243
Drug-inuced Liver Injury (DILI):  0.237
AMES Toxicity:  0.017
Rat Oral Acute Toxicity:  0.807
Maximum Recommended Daily Dose:  0.929
Skin Sensitization:  0.103
Carcinogencity:  0.893
Eye Corrosion:  0.003
Eye Irritation:  0.01
Respiratory Toxicity:  0.715

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC471854

Natural Product ID:  NPC471854
Common Name*:   2Beta,3Alpha,16Alpha,20,25-Tetrahydroxycucurbita-5,23(E)-Diene-11,22-Dione-16-Acetate
IUPAC Name:   [(2S,3S,8S,9R,10R,13R,14S,16R,17R)-17-[(E)-2,6-dihydroxy-6-methyl-3-oxohept-4-en-2-yl]-2,3-dihydroxy-4,4,9,13,14-pentamethyl-11-oxo-1,2,3,7,8,10,12,15,16,17-decahydrocyclopenta[a]phenanthren-16-yl] acetate
Synonyms:  
Standard InCHIKey:  PKTPBFBNOBGLCY-MZRCPWCYSA-N
Standard InCHI:  InChI=1S/C32H48O8/c1-17(33)40-21-15-29(6)22-11-10-18-19(14-20(34)26(37)28(18,4)5)31(22,8)24(36)16-30(29,7)25(21)32(9,39)23(35)12-13-27(2,3)38/h10,12-13,19-22,25-26,34,37-39H,11,14-16H2,1-9H3/b13-12+/t19-,20+,21-,22+,25+,26-,29+,30-,31+,32?/m1/s1
SMILES:  CC(=O)O[C@@H]1C[C@@]2([C@]([C@H]1C(C(=O)/C=C/C(O)(C)C)(O)C)(C)CC(=O)[C@@]1([C@H]2CC=C2[C@H]1C[C@@H]([C@H](C2(C)C)O)O)C)C
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL3261680
PubChem CID:   90676075
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000012] Lipids and lipid-like molecules
      • [CHEMONTID:0000258] Steroids and steroid derivatives
        • [CHEMONTID:0001686] Cucurbitacins

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33474 hemsleya penxianensis Species Cucurbitaceae Eukaryota n.a. n.a. n.a. PMID[24717151]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT323 Cell Line SW-620 Homo sapiens IC50 = 0.42 ug.mL-1 PMID[515046]
NPT407 Cell Line COLO 205 Homo sapiens IC50 = 0.44 ug.mL-1 PMID[515046]
NPT20529 NON-MOLECULAR NON-PROTEIN TARGET n.a. IC50 = 3.43 ug.mL-1 PMID[515046]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC471854 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9725 High Similarity NPC257457
0.9725 High Similarity NPC311554
0.9346 High Similarity NPC214644
0.9266 High Similarity NPC475524
0.9266 High Similarity NPC100267
0.9189 High Similarity NPC148458
0.9091 High Similarity NPC280782
0.9043 High Similarity NPC222688
0.9009 High Similarity NPC250109
0.9009 High Similarity NPC962
0.8938 High Similarity NPC239273
0.8919 High Similarity NPC221144
0.8898 High Similarity NPC470882
0.8879 High Similarity NPC311612
0.887 High Similarity NPC109973
0.886 High Similarity NPC329736
0.885 High Similarity NPC49492
0.885 High Similarity NPC266728
0.8839 High Similarity NPC108721
0.8839 High Similarity NPC73300
0.8807 High Similarity NPC185
0.8807 High Similarity NPC475294
0.8807 High Similarity NPC44063
0.8785 High Similarity NPC477915
0.8785 High Similarity NPC87351
0.8783 High Similarity NPC61520
0.8761 High Similarity NPC147912
0.8761 High Similarity NPC67259
0.876 High Similarity NPC471855
0.875 High Similarity NPC147180
0.875 High Similarity NPC264634
0.875 High Similarity NPC71348
0.8739 High Similarity NPC473265
0.8716 High Similarity NPC149047
0.8684 High Similarity NPC270958
0.8684 High Similarity NPC270929
0.8661 High Similarity NPC43775
0.8649 High Similarity NPC11710
0.8649 High Similarity NPC2766
0.8636 High Similarity NPC220229
0.8636 High Similarity NPC475060
0.8636 High Similarity NPC83744
0.8636 High Similarity NPC477916
0.8624 High Similarity NPC209502
0.8624 High Similarity NPC204833
0.8621 High Similarity NPC472933
0.8621 High Similarity NPC264954
0.8621 High Similarity NPC475041
0.8611 High Similarity NPC136289
0.8611 High Similarity NPC473424
0.8609 High Similarity NPC470959
0.8609 High Similarity NPC472934
0.8609 High Similarity NPC476965
0.8595 High Similarity NPC471407
0.8595 High Similarity NPC470880
0.8584 High Similarity NPC207251
0.8583 High Similarity NPC473253
0.8571 High Similarity NPC473255
0.8571 High Similarity NPC76084
0.8559 High Similarity NPC217201
0.8559 High Similarity NPC269642
0.8559 High Similarity NPC329417
0.8559 High Similarity NPC295244
0.8547 High Similarity NPC474370
0.8545 High Similarity NPC171137
0.8545 High Similarity NPC152695
0.8545 High Similarity NPC260268
0.8545 High Similarity NPC476027
0.8545 High Similarity NPC150531
0.8545 High Similarity NPC50692
0.8545 High Similarity NPC85829
0.8545 High Similarity NPC48733
0.8545 High Similarity NPC319077
0.8545 High Similarity NPC97202
0.8545 High Similarity NPC296945
0.8545 High Similarity NPC257353
0.8545 High Similarity NPC49958
0.8545 High Similarity NPC196528
0.8545 High Similarity NPC302607
0.8545 High Similarity NPC202167
0.8545 High Similarity NPC181265
0.8545 High Similarity NPC214264
0.8534 High Similarity NPC118638
0.8532 High Similarity NPC191892
0.8532 High Similarity NPC111323
0.8532 High Similarity NPC264048
0.8519 High Similarity NPC476240
0.8519 High Similarity NPC224720
0.8519 High Similarity NPC476223
0.8519 High Similarity NPC81530
0.8509 High Similarity NPC472929
0.8509 High Similarity NPC202889
0.8509 High Similarity NPC472926
0.8509 High Similarity NPC317210
0.8487 Intermediate Similarity NPC473979
0.8482 Intermediate Similarity NPC241927
0.8482 Intermediate Similarity NPC258543
0.8482 Intermediate Similarity NPC41405
0.8482 Intermediate Similarity NPC304495
0.8468 Intermediate Similarity NPC473284
0.8468 Intermediate Similarity NPC165873
0.8462 Intermediate Similarity NPC473270
0.8455 Intermediate Similarity NPC137657
0.8455 Intermediate Similarity NPC235889
0.8448 Intermediate Similarity NPC470492
0.8448 Intermediate Similarity NPC286528
0.8448 Intermediate Similarity NPC20302
0.8448 Intermediate Similarity NPC472927
0.8448 Intermediate Similarity NPC140055
0.8448 Intermediate Similarity NPC167606
0.8443 Intermediate Similarity NPC231529
0.844 Intermediate Similarity NPC119601
0.844 Intermediate Similarity NPC308726
0.844 Intermediate Similarity NPC473928
0.8435 Intermediate Similarity NPC326542
0.8426 Intermediate Similarity NPC476274
0.8426 Intermediate Similarity NPC316964
0.8426 Intermediate Similarity NPC144956
0.8421 Intermediate Similarity NPC170487
0.8417 Intermediate Similarity NPC81736
0.8417 Intermediate Similarity NPC172154
0.8407 Intermediate Similarity NPC37116
0.8407 Intermediate Similarity NPC239097
0.8407 Intermediate Similarity NPC5284
0.8407 Intermediate Similarity NPC197428
0.8407 Intermediate Similarity NPC473627
0.8403 Intermediate Similarity NPC88326
0.8403 Intermediate Similarity NPC28532
0.8403 Intermediate Similarity NPC153700
0.8393 Intermediate Similarity NPC472218
0.8393 Intermediate Similarity NPC472219
0.8393 Intermediate Similarity NPC472825
0.8393 Intermediate Similarity NPC65941
0.8393 Intermediate Similarity NPC472217
0.839 Intermediate Similarity NPC476961
0.8378 Intermediate Similarity NPC323834
0.8376 Intermediate Similarity NPC50774
0.8376 Intermediate Similarity NPC709
0.8374 Intermediate Similarity NPC196921
0.8374 Intermediate Similarity NPC220757
0.8364 Intermediate Similarity NPC236390
0.8364 Intermediate Similarity NPC247957
0.8364 Intermediate Similarity NPC249187
0.8362 Intermediate Similarity NPC64318
0.8349 Intermediate Similarity NPC115899
0.8349 Intermediate Similarity NPC163372
0.8349 Intermediate Similarity NPC302537
0.8348 Intermediate Similarity NPC122056
0.8348 Intermediate Similarity NPC194100
0.8347 Intermediate Similarity NPC15095
0.8347 Intermediate Similarity NPC293112
0.8347 Intermediate Similarity NPC473635
0.8333 Intermediate Similarity NPC11895
0.8333 Intermediate Similarity NPC472928
0.8333 Intermediate Similarity NPC469789
0.8333 Intermediate Similarity NPC214797
0.8333 Intermediate Similarity NPC118860
0.8333 Intermediate Similarity NPC197386
0.8333 Intermediate Similarity NPC231589
0.8319 Intermediate Similarity NPC46570
0.8319 Intermediate Similarity NPC475941
0.8319 Intermediate Similarity NPC474901
0.8305 Intermediate Similarity NPC5292
0.8304 Intermediate Similarity NPC220974
0.8304 Intermediate Similarity NPC471783
0.8304 Intermediate Similarity NPC9457
0.8304 Intermediate Similarity NPC472925
0.8293 Intermediate Similarity NPC35109
0.8291 Intermediate Similarity NPC243065
0.8291 Intermediate Similarity NPC470493
0.8291 Intermediate Similarity NPC312824
0.8291 Intermediate Similarity NPC284068
0.8291 Intermediate Similarity NPC183580
0.8288 Intermediate Similarity NPC75531
0.8288 Intermediate Similarity NPC118911
0.8288 Intermediate Similarity NPC149124
0.8273 Intermediate Similarity NPC195290
0.8273 Intermediate Similarity NPC56498
0.8273 Intermediate Similarity NPC204450
0.8264 Intermediate Similarity NPC3381
0.8264 Intermediate Similarity NPC8369
0.8264 Intermediate Similarity NPC8374
0.8261 Intermediate Similarity NPC475970
0.8261 Intermediate Similarity NPC191620
0.8261 Intermediate Similarity NPC234042
0.8261 Intermediate Similarity NPC152117
0.8257 Intermediate Similarity NPC266955
0.825 Intermediate Similarity NPC470265
0.825 Intermediate Similarity NPC107493
0.825 Intermediate Similarity NPC170538
0.825 Intermediate Similarity NPC23786
0.8246 Intermediate Similarity NPC129689
0.8241 Intermediate Similarity NPC18509
0.8241 Intermediate Similarity NPC107243
0.824 Intermediate Similarity NPC469673
0.8235 Intermediate Similarity NPC79579
0.8235 Intermediate Similarity NPC471406
0.823 Intermediate Similarity NPC177064
0.823 Intermediate Similarity NPC94529
0.8224 Intermediate Similarity NPC469599

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC471854 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9091 High Similarity NPD8297 Approved
0.9 High Similarity NPD6649 Approved
0.9 High Similarity NPD6650 Approved
0.8899 High Similarity NPD6899 Approved
0.8899 High Similarity NPD6881 Approved
0.8829 High Similarity NPD8130 Phase 1
0.8818 High Similarity NPD6372 Approved
0.8818 High Similarity NPD6373 Approved
0.8807 High Similarity NPD5697 Approved
0.875 High Similarity NPD6882 Approved
0.8739 High Similarity NPD6883 Approved
0.8739 High Similarity NPD7102 Approved
0.8739 High Similarity NPD7290 Approved
0.8716 High Similarity NPD5739 Approved
0.8716 High Similarity NPD6675 Approved
0.8716 High Similarity NPD7128 Approved
0.8716 High Similarity NPD6402 Approved
0.8661 High Similarity NPD6869 Approved
0.8661 High Similarity NPD6617 Approved
0.8661 High Similarity NPD6847 Approved
0.8649 High Similarity NPD6013 Approved
0.8649 High Similarity NPD6014 Approved
0.8649 High Similarity NPD6012 Approved
0.8611 High Similarity NPD5211 Phase 2
0.8559 High Similarity NPD7320 Approved
0.8559 High Similarity NPD6011 Approved
0.8468 Intermediate Similarity NPD5701 Approved
0.8455 Intermediate Similarity NPD5141 Approved
0.8448 Intermediate Similarity NPD7115 Discovery
0.8426 Intermediate Similarity NPD5286 Approved
0.8426 Intermediate Similarity NPD5285 Approved
0.8426 Intermediate Similarity NPD4696 Approved
0.839 Intermediate Similarity NPD6319 Approved
0.8348 Intermediate Similarity NPD4632 Approved
0.8273 Intermediate Similarity NPD5226 Approved
0.8273 Intermediate Similarity NPD5224 Approved
0.8273 Intermediate Similarity NPD5225 Approved
0.8273 Intermediate Similarity NPD4633 Approved
0.8241 Intermediate Similarity NPD4755 Approved
0.8241 Intermediate Similarity NPD6084 Phase 2
0.8241 Intermediate Similarity NPD6083 Phase 2
0.8198 Intermediate Similarity NPD5174 Approved
0.8198 Intermediate Similarity NPD5175 Approved
0.8182 Intermediate Similarity NPD5223 Approved
0.8174 Intermediate Similarity NPD6401 Clinical (unspecified phase)
0.8151 Intermediate Similarity NPD7100 Approved
0.8151 Intermediate Similarity NPD7101 Approved
0.8091 Intermediate Similarity NPD4700 Approved
0.8087 Intermediate Similarity NPD4634 Approved
0.807 Intermediate Similarity NPD4730 Approved
0.807 Intermediate Similarity NPD4729 Approved
0.8067 Intermediate Similarity NPD6335 Approved
0.8051 Intermediate Similarity NPD6274 Approved
0.8 Intermediate Similarity NPD5696 Approved
0.7983 Intermediate Similarity NPD6317 Approved
0.7983 Intermediate Similarity NPD6009 Approved
0.7982 Intermediate Similarity NPD5220 Clinical (unspecified phase)
0.7982 Intermediate Similarity NPD5221 Approved
0.7982 Intermediate Similarity NPD5222 Approved
0.7967 Intermediate Similarity NPD7492 Approved
0.7944 Intermediate Similarity NPD6079 Approved
0.7934 Intermediate Similarity NPD6054 Approved
0.7931 Intermediate Similarity NPD5250 Approved
0.7931 Intermediate Similarity NPD5251 Approved
0.7931 Intermediate Similarity NPD5249 Phase 3
0.7931 Intermediate Similarity NPD5248 Approved
0.7931 Intermediate Similarity NPD5247 Approved
0.792 Intermediate Similarity NPD7736 Approved
0.7917 Intermediate Similarity NPD6314 Approved
0.7917 Intermediate Similarity NPD6313 Approved
0.7909 Intermediate Similarity NPD5173 Approved
0.7903 Intermediate Similarity NPD6616 Approved
0.7895 Intermediate Similarity NPD4768 Approved
0.7895 Intermediate Similarity NPD4767 Approved
0.789 Intermediate Similarity NPD5210 Approved
0.789 Intermediate Similarity NPD5695 Phase 3
0.789 Intermediate Similarity NPD4629 Approved
0.7886 Intermediate Similarity NPD7604 Phase 2
0.7869 Intermediate Similarity NPD5983 Phase 2
0.7869 Intermediate Similarity NPD6291 Clinical (unspecified phase)
0.784 Intermediate Similarity NPD7078 Approved
0.7818 Intermediate Similarity NPD4697 Phase 3
0.7805 Intermediate Similarity NPD6370 Approved
0.776 Intermediate Similarity NPD6336 Discontinued
0.7759 Intermediate Similarity NPD5128 Approved
0.7757 Intermediate Similarity NPD4753 Phase 2
0.7757 Intermediate Similarity NPD5328 Approved
0.775 Intermediate Similarity NPD6868 Approved
0.7739 Intermediate Similarity NPD6008 Approved
0.7724 Intermediate Similarity NPD6016 Approved
0.7724 Intermediate Similarity NPD6015 Approved
0.7724 Intermediate Similarity NPD6909 Approved
0.7724 Intermediate Similarity NPD6908 Approved
0.7719 Intermediate Similarity NPD4754 Approved
0.7712 Intermediate Similarity NPD5216 Approved
0.7712 Intermediate Similarity NPD5215 Approved
0.7712 Intermediate Similarity NPD5217 Approved
0.7706 Intermediate Similarity NPD6399 Phase 3
0.7698 Intermediate Similarity NPD8293 Discontinued
0.7661 Intermediate Similarity NPD5988 Approved
0.7642 Intermediate Similarity NPD6059 Approved
0.7627 Intermediate Similarity NPD5135 Approved
0.7627 Intermediate Similarity NPD5134 Clinical (unspecified phase)
0.7627 Intermediate Similarity NPD5169 Approved
0.7619 Intermediate Similarity NPD7507 Approved
0.7611 Intermediate Similarity NPD7640 Approved
0.7611 Intermediate Similarity NPD7639 Approved
0.7593 Intermediate Similarity NPD6904 Approved
0.7593 Intermediate Similarity NPD6080 Approved
0.7593 Intermediate Similarity NPD6673 Approved
0.7568 Intermediate Similarity NPD6356 Clinical (unspecified phase)
0.7563 Intermediate Similarity NPD5127 Approved
0.7545 Intermediate Similarity NPD4202 Approved
0.7522 Intermediate Similarity NPD7638 Approved
0.7522 Intermediate Similarity NPD4225 Approved
0.75 Intermediate Similarity NPD6672 Approved
0.75 Intermediate Similarity NPD5737 Approved
0.7477 Intermediate Similarity NPD7146 Approved
0.7477 Intermediate Similarity NPD7521 Approved
0.7477 Intermediate Similarity NPD7334 Approved
0.7477 Intermediate Similarity NPD7748 Approved
0.7477 Intermediate Similarity NPD6409 Approved
0.7477 Intermediate Similarity NPD3618 Phase 1
0.7477 Intermediate Similarity NPD6684 Approved
0.7477 Intermediate Similarity NPD5330 Approved
0.7455 Intermediate Similarity NPD5693 Phase 1
0.7442 Intermediate Similarity NPD7319 Approved
0.7434 Intermediate Similarity NPD7902 Approved
0.7383 Intermediate Similarity NPD5329 Approved
0.7377 Intermediate Similarity NPD5167 Approved
0.7339 Intermediate Similarity NPD6903 Approved
0.7339 Intermediate Similarity NPD7513 Clinical (unspecified phase)
0.7323 Intermediate Similarity NPD8328 Phase 3
0.7315 Intermediate Similarity NPD5690 Phase 2
0.7315 Intermediate Similarity NPD6098 Approved
0.7311 Intermediate Similarity NPD5345 Clinical (unspecified phase)
0.7311 Intermediate Similarity NPD5168 Approved
0.7297 Intermediate Similarity NPD5284 Approved
0.7297 Intermediate Similarity NPD5281 Approved
0.7297 Intermediate Similarity NPD5694 Approved
0.7297 Intermediate Similarity NPD6050 Approved
0.7297 Intermediate Similarity NPD7515 Phase 2
0.729 Intermediate Similarity NPD3133 Approved
0.729 Intermediate Similarity NPD4197 Approved
0.729 Intermediate Similarity NPD3666 Approved
0.729 Intermediate Similarity NPD4786 Approved
0.729 Intermediate Similarity NPD3665 Phase 1
0.7248 Intermediate Similarity NPD3573 Approved
0.7227 Intermediate Similarity NPD6412 Phase 2
0.7213 Intermediate Similarity NPD6053 Discontinued
0.7207 Intermediate Similarity NPD5692 Phase 3
0.7207 Intermediate Similarity NPD5785 Approved
0.7168 Intermediate Similarity NPD7901 Clinical (unspecified phase)
0.7168 Intermediate Similarity NPD6001 Approved
0.7168 Intermediate Similarity NPD7900 Approved
0.7165 Intermediate Similarity NPD8033 Approved
0.7165 Intermediate Similarity NPD7503 Approved
0.7156 Intermediate Similarity NPD3574 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD8034 Phase 2
0.7143 Intermediate Similarity NPD7516 Approved
0.7143 Intermediate Similarity NPD8035 Phase 2
0.7107 Intermediate Similarity NPD4061 Clinical (unspecified phase)
0.7103 Intermediate Similarity NPD3667 Approved
0.7103 Intermediate Similarity NPD4223 Phase 3
0.7103 Intermediate Similarity NPD4221 Approved
0.7099 Intermediate Similarity NPD6033 Approved
0.7087 Intermediate Similarity NPD8294 Approved
0.7087 Intermediate Similarity NPD8377 Approved
0.7083 Intermediate Similarity NPD6614 Approved
0.7064 Intermediate Similarity NPD5363 Approved
0.7063 Intermediate Similarity NPD7328 Approved
0.7063 Intermediate Similarity NPD7327 Approved
0.7054 Intermediate Similarity NPD5207 Approved
0.7049 Intermediate Similarity NPD5955 Clinical (unspecified phase)
0.7034 Intermediate Similarity NPD7632 Discontinued
0.7031 Intermediate Similarity NPD8296 Approved
0.7031 Intermediate Similarity NPD8379 Approved
0.7031 Intermediate Similarity NPD8378 Approved
0.7031 Intermediate Similarity NPD8380 Approved
0.7031 Intermediate Similarity NPD8335 Approved
0.7027 Intermediate Similarity NPD5208 Approved
0.7025 Intermediate Similarity NPD6686 Approved
0.7 Intermediate Similarity NPD5786 Approved
0.7 Intermediate Similarity NPD5279 Phase 3
0.7 Intermediate Similarity NPD5280 Approved
0.7 Intermediate Similarity NPD4694 Approved
0.6993 Remote Similarity NPD7236 Approved
0.6991 Remote Similarity NPD6411 Approved
0.6984 Remote Similarity NPD8295 Clinical (unspecified phase)
0.6967 Remote Similarity NPD8132 Clinical (unspecified phase)
0.6942 Remote Similarity NPD7899 Clinical (unspecified phase)
0.694 Remote Similarity NPD7260 Phase 2
0.693 Remote Similarity NPD5778 Approved
0.693 Remote Similarity NPD5779 Approved
0.6911 Remote Similarity NPD6371 Approved
0.6909 Remote Similarity NPD1694 Approved
0.6909 Remote Similarity NPD7520 Clinical (unspecified phase)
0.6891 Remote Similarity NPD5091 Approved
0.6881 Remote Similarity NPD4788 Approved
0.6881 Remote Similarity NPD5362 Discontinued

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data